• OPEN AN ACCOUNT
Indian Indices
Nifty
25,597.65 -165.70
(-0.64%)
Sensex
83,459.15 -519.34
( -0.62%)
Bank Nifty
57,827.05 -274.40
( -0.47%)
Nifty IT
35,274.55 -378.50
( -1.06%)
Global Indices
Nasdaq
47,102.64 -255.05
(-0.54%)
Dow Jones
6,792.56 -80.41
(-1.17%)
Hang Seng
50,042.66 -1,454.54
(-2.82%)
Nikkei 225
9,700.69 -0.68
(-0.01%)
Forex
USD-INR
88.75 0.20
(0.23%)
EUR-INR
102.26 0.13
(0.13%)
GBP-INR
116.57 0.18
(0.16%)
JPY-INR
0.58 0.00
(0.17%)

EQUITY - MARKET SCREENER

Ganesh Infraworld Ltd
Industry :  Construction
BSE Code
ISIN Demat
Book Value()
93637
INE0TVT01024
42.023602
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GANESHIN
21.44
957.39
EPS(TTM)
Face Value()
Div & Yield %
10.45
5
0
 

Fredun Pharma gains after launching new product
Oct 13,2025
The product, launched under Fredun's Freossi brand, is free from root vegetables, meat, and animal-derived ingredients, in line with Jain dietary principles. It is designed to support pet immunity, digestion, bone health, and energy.

Snacky Jain will be initially available in six cities through veterinary clinics, online platforms, and retail partners, with expansion planned for Ahmedabad, Pune, Bengaluru, and Delhi.

The product is manufactured at the company’s WHO-GMP-certified Palghar facility. Fredun said the launch strengthens its position in India's pet healthcare market, estimated at Rs 10,000 crore and growing at over 22% annually.

Fredun Pharmaceuticals, a healthcare and pharmaceuticals company offer a range of products, including antihypertensives, antidiabetic, antiretroviral drugs (ARVs) and narcotics. It is also engaged in the manufacturing of dietary/herbal supplements, nutraceuticals, cosmeceuticals, and other healthcare products along with animal healthcare products. The company primarily exports its products to Africa, Southeast Asia, Commonwealth of Independent States (CIS) countries and Latin America.

On a standalone basis, Fredun Pharmaceuticals' net profit rose 63.92% to Rs 6.77 crore while net sales rose 53.99% to Rs 119.40 crore in Q1 June 2025 over Q1 June 2024.